002099 海翔药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额139,496240,537116,092102,361533,870
投资活动产生之现金流量净额(105,303)(128,215)(620,316)(509,007)(70,581)
筹资活动产生之现金流量净额(88,620)99,070(121,882)80,786(11,189)
汇率变动对现金及现金等价物的影响13,6151,10475,133(25,534)(38,476)
现金及现金等价物净增加/(减少)(40,811)212,496(550,973)(351,394)413,624
期初现金及现金等价物余额1,249,5311,037,0351,588,0081,939,4021,525,778
期末现金及现金等价物余额1,208,7191,249,5311,037,0351,588,0081,939,402